Hepion Pharmaceuticals Inc (HEPA)

[couldbebetter]

BOMC, The company in the past has had a reverse stock split. Investors
fear management will do this again. Company will eventually need a
Phase 3 clinical trial so it is estimated results from such may not be
out until 2025-2026. If all goes well and substantial dilution is
avoided this stock could be a 100X gainer. The best way to play this
is to simply buy some stock and then sell call options until it is
called away. Might not get a 100X but could get you a double sooner
or later. Their only drug looks to be a winner if they can get it
through the gauntlet and perhaps reap the rewards of a BO.